Okay, let's tackle this question about Refsum's disease. The question is asking which enzyme deficiency causes Refsum's disease. First, I need to recall what Refsum's disease is. From what I remember, it's a rare inherited metabolic disorder. It's related to the metabolism of phytanic acid.

So, phytanic acid is a branched-chain fatty acid found in certain foods like dairy and meat. Normally, the body breaks down phytanic acid through a process called alpha-oxidation. The key enzyme here is probably involved in that pathway. If there's a deficiency, phytanic acid can accumulate, leading to the symptoms of Refsum's disease, like peripheral neuropathy, retinitis pigmentosa, and cerebellar ataxia.

Now, the enzymes involved in phytanic acid metabolism. The main pathway is alpha-oxidation, which occurs in peroxisomes. The first step in this pathway is catalyzed by phytanoyl-CoA hydroxylase. If that enzyme is deficient, phytanic acid can't be broken down, leading to its accumulation. So, the correct answer should be phytanoyl-CoA hydroxylase deficiency.

Looking at the options given, the correct answer would be the option that lists this enzyme. The other options might include enzymes related to other metabolic disorders. For example, deficiencies in other peroxisomal enzymes like those in Zellweger syndrome or X-linked adrenoleukodystrophy could be distractors. Also, enzymes involved in beta-oxidation or other fatty acid pathways might be included to confuse.

Wait, let me make sure. Refsum's disease is specifically due to phytanoyl-CoA hydroxylase deficiency. Other peroxisomal disorders have different enzyme deficiencies. For example, Zellweger syndrome is due to PEX gene mutations affecting peroxisome biogenesis. X-linked adrenoleukodystrophy involves ABCD1 transporter deficiency. So, the incorrect options would likely be those enzymes.

So, if the options include phytanoyl-CoA hydroxylase (option C, say), then that's correct. The other options would be enzymes like acyl-CoA dehydrogenase (involved in beta-oxidation), or those in Zellweger or other peroxisomal diseases. Each incorrect option would be a different enzyme from other metabolic pathways.

The clinical pearl here is that Refsum's disease is managed with a phytanic acid-restricted diet, which helps reduce symptoms. Also, the key enzyme in this disease is phytanoyl-CoA hydroxylase, so that's a high-yield fact for exams. Students should remember that this enzyme is specific to the alpha-oxidation of phytanic acid in peroxisomes.

**Core Concept**
Refsum's disease is an autosomal recessive disorder caused by impaired alpha-oxidation of phytanic acid, a branched-chain fatty acid. The deficiency of **phytanoyl-CoA hydroxylase** in peroxisomes prevents phytanic acid breakdown, leading to its toxic accumulation and multisystem damage.

**Why the Correct Answer is Right**
Phytanic acid is metabolized via alpha-oxidation in peroxisomes, initiated by phytanoyl

✓ Correct Answer: D. Phytanic alpha oxidase